[go: up one dir, main page]

WO2008142483A3 - Compositions vaccinales et procédés d'utilisation de celles-ci - Google Patents

Compositions vaccinales et procédés d'utilisation de celles-ci Download PDF

Info

Publication number
WO2008142483A3
WO2008142483A3 PCT/IB2007/004614 IB2007004614W WO2008142483A3 WO 2008142483 A3 WO2008142483 A3 WO 2008142483A3 IB 2007004614 W IB2007004614 W IB 2007004614W WO 2008142483 A3 WO2008142483 A3 WO 2008142483A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
vaccine compositions
immunization
compositions
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/004614
Other languages
English (en)
Other versions
WO2008142483A2 (fr
Inventor
Gerard J A Rouwendal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IQ Corp BV
Original Assignee
IQ Corp BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IQ Corp BV filed Critical IQ Corp BV
Publication of WO2008142483A2 publication Critical patent/WO2008142483A2/fr
Publication of WO2008142483A3 publication Critical patent/WO2008142483A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6056—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des compositions vaccinales et des procédés d'immunisation.
PCT/IB2007/004614 2006-12-14 2007-12-14 Compositions vaccinales et procédés d'utilisation de celles-ci Ceased WO2008142483A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86992606P 2006-12-14 2006-12-14
US60/869,926 2006-12-14

Publications (2)

Publication Number Publication Date
WO2008142483A2 WO2008142483A2 (fr) 2008-11-27
WO2008142483A3 true WO2008142483A3 (fr) 2009-04-02

Family

ID=40032227

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/004614 Ceased WO2008142483A2 (fr) 2006-12-14 2007-12-14 Compositions vaccinales et procédés d'utilisation de celles-ci

Country Status (1)

Country Link
WO (1) WO2008142483A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2490707B1 (fr) * 2009-10-21 2016-07-27 ETH Zurich Utilité médicale des protéines liant les glycanes et des glycanes

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153871A2 (fr) * 1984-03-01 1985-09-04 Centocor, Inc. Augmentation de l'immunogénéité d'un antigène par anticorps
WO1997035884A1 (fr) * 1996-03-27 1997-10-02 The Binding Site Limited Production amelioree d'anticorps par l'utilisation de complexes antigene-anticorps
WO2007073567A2 (fr) * 2005-12-22 2007-06-28 Iq Corporation Compositions et procedes pour la modulation de la reponse immunitaire

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153871A2 (fr) * 1984-03-01 1985-09-04 Centocor, Inc. Augmentation de l'immunogénéité d'un antigène par anticorps
WO1997035884A1 (fr) * 1996-03-27 1997-10-02 The Binding Site Limited Production amelioree d'anticorps par l'utilisation de complexes antigene-anticorps
WO2007073567A2 (fr) * 2005-12-22 2007-06-28 Iq Corporation Compositions et procedes pour la modulation de la reponse immunitaire

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BARDOR MURIEL ET AL: "Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)-fucose and core xylose.", GLYCOBIOLOGY, vol. 13, no. 6, June 2003 (2003-06-01), pages 427 - 434, XP002511668, ISSN: 0959-6658 *
FAYE L ET AL: "Affinity Purification of Antibodies Specific for Asn-Linked Glycans Containing alpha1 -> 3 Fucose or beta1 -> 2 Xylose", ANALYTICAL BIOCHEMISTRY, ACADEMIC PRESS INC. NEW YORK, vol. 209, no. 1, 15 February 1993 (1993-02-15), pages 104 - 108, XP024763726, ISSN: 0003-2697, [retrieved on 19930215] *
WEN Y ET AL: "ENHANCED IMMUNOGENICITY IN MICE WITH HEPATITIS B VACCINE COMPLEXED TO HUMAN HEPATITIS B IMMUNOGLOBULIN", CHINESE MEDICAL JOURNAL / ZHONGHUA YIXUE ZAZHI YINGWEN BAN, CHINESE MEDICAL ASSOCIATION, BEIJING, CN, vol. 107, no. 10, 1 January 1994 (1994-01-01), pages 741 - 744, XP002940345, ISSN: 0366-6999 *

Also Published As

Publication number Publication date
WO2008142483A2 (fr) 2008-11-27

Similar Documents

Publication Publication Date Title
WO2008100805A3 (fr) Anticorps anti-robo4 et utilisations de ceux-ci
WO2008060705A3 (fr) Anticorps anti-dll4 et leurs procédés d'utilisation
WO2007127841A3 (fr) Compositions et leurs méthodes d'élaboration
WO2008124660A3 (fr) Procédés et compositions pour le traitement du cancer
WO2011031896A3 (fr) Inhibiteurs de pi3 kinase et leurs utilisations
WO2007133290A8 (fr) Anticorps anti-ox40l et méthodes correspondantes
WO2008127290A3 (fr) Compositions d'alginate et d'alginate-lyase et procédés d'utilisation
WO2008057550A3 (fr) Stabilisation de vaccins par lyophilisation
WO2008127226A3 (fr) Antagonistes de kinase p13
PH12015500550A1 (en) Anti-notch1 nrr antibodies and methods using same
WO2007130697A8 (fr) Anticorps anti-ephb4 et procedes qui les utilisent
WO2011072099A3 (fr) Compositions et procédés comprenant des variants de protéase
WO2009082701A8 (fr) Inhibiteurs de hcv protéase et leurs utilisations
WO2007124090A3 (fr) Formulations de molécule peptide(s)-anticorps thérapeutique lyophilisée
WO2008121767A3 (fr) Polypeptides cousus
UA97502C2 (ru) Кристаллическая твердая основа разагилина
WO2011002808A8 (fr) Inhibiteurs de la protéase du vhc et leurs utilisations
WO2008054481A3 (fr) Meilleures compositions de virus influenza inactivé
WO2008112192A3 (fr) Anticorps epha3 utilises dans le traitement des tumeurs solides
WO2008025015A8 (fr) Échafaudages d'épitope et de transplant et leurs utilsation
WO2007127506A8 (fr) Anticorps anti-ephrinb2 et procédés les utilisant
WO2007106915A8 (fr) Anticorps à efgl 7 et leurs procédés d'utilisation
WO2005082020A3 (fr) Vaccin du flavivirus
WO2006091722A3 (fr) Vaccination amplifiee par alkyle-glycosides
WO2011050188A8 (fr) Anticorps anti-hepsine et procédés d'utilisation de ceux-ci

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07874034

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 07874034

Country of ref document: EP

Kind code of ref document: A2